{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T20:07:03Z","timestamp":1787602023193,"version":"build-2736575974"},"reference-count":23,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T00:00:00Z","timestamp":1712534400000},"content-version":"vor","delay-in-days":1315,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Medicine"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.7861\/clinmed.2019-0488","type":"journal-article","created":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T09:25:11Z","timestamp":1600161911000},"page":"e191-e195","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Clinical presentation and outcomes of solitary plasmacytoma in a tertiary hospital in the UK"],"prefix":"10.1016","volume":"20","author":[{"given":"Charles","family":"Agbuduwe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiqi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jigisha","family":"Gaglani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thankamma","family":"Ajithkumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.7861\/clinmed.2019-0488_bib1","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.7861\/clinmed.2019-0488_bib2","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1182\/blood-2014-04-566521","article-title":"Outcome prediction in plasmacytoma of bone: a risk model utilizing bone marrow flow cytometry and light-chain analysis","volume":"124","author":"Hill","year":"2014","journal-title":"Blood"},{"key":"10.7861\/clinmed.2019-0488_bib3","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1038\/leu.2013.166","article-title":"A multiparameter flow cytometry immunophenotypic algorithm for the identification of newly diagnosed symptomatic myeloma with an MGUS-like signature and long-term disease control","volume":"27","author":"Paiva","year":"2013","journal-title":"Leukemia"},{"key":"10.7861\/clinmed.2019-0488_bib4","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/ajh.23201","article-title":"Trends and outcomes of modern staging of solitary plasmacytoma of bone","volume":"87","author":"Warsame","year":"2012","journal-title":"Am J Hematol"},{"key":"10.7861\/clinmed.2019-0488_bib5","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1182\/blood-2006-04-015784","article-title":"Immunoglobulin free light chains and solitary plasmacytoma of bone","volume":"108","author":"Dingli","year":"2006","journal-title":"Blood"},{"key":"10.7861\/clinmed.2019-0488_bib6","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/bjh.14291","article-title":"Progression of a solitary plasmacytoma to multiple myeloma. A population-based registry of the northern Netherlands","volume":"175","author":"de Waal","year":"2016","journal-title":"Br J Haematol"},{"key":"10.7861\/clinmed.2019-0488_bib7","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/1471-2407-6-118","article-title":"Prognostic factors in solitary plasmacytoma of the bone: a multicenter Rare Cancer Network study","volume":"6","author":"Knobel","year":"2006","journal-title":"BMC Cancer"},{"key":"10.7861\/clinmed.2019-0488_bib8","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1002\/cncr.10366","article-title":"Persistence of myeloma protein for more than one year after radiotherapy is an adverse prognostic factor in solitary plasmacytoma of bone","volume":"94","author":"Wilder","year":"2002","journal-title":"Cancer"},{"key":"10.7861\/clinmed.2019-0488_bib9","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1182\/blood-2006-04-015784","article-title":"Immunoglobulin free light chains and solitary plasmacytoma of bone","volume":"108","author":"Dingli","year":"2006","journal-title":"Blood"},{"key":"10.7861\/clinmed.2019-0488_bib10","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0360-3016(00)01572-8","article-title":"Solitary plasmacytoma treated with radiotherapy: Impact of tumor size on outcome","volume":"50","author":"Tsang","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.7861\/clinmed.2019-0488_bib11","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ijrobp.2005.06.039","article-title":"Outcomes and patterns of failure in solitary plasmacytoma: A multicenter Rare Cancer Network study of 258 patients","volume":"64","author":"Ozsahin","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.7861\/clinmed.2019-0488_bib12","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/bjh.14189","article-title":"Clinical risk factors of plasmacytoma mortality: a US population-based study","volume":"179","author":"El-Fattah","year":"2017","journal-title":"Br J Haematol"},{"key":"10.7861\/clinmed.2019-0488_bib13","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJMoa01133202","article-title":"A long-term study of prognosis in monoclonal gammopathy of undetermined significance","volume":"346","author":"Kyle","year":"2002","journal-title":"N Engl J Med"},{"key":"10.7861\/clinmed.2019-0488_bib14","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/hon.2415","article-title":"Long-term outcome of patients with solitary plasmacytoma treated with radiotherapy: A population-based, single-center study with median follow-up of 13.7 years","volume":"36","author":"Barzenje","year":"2018","journal-title":"Hematol Oncol"},{"key":"10.7861\/clinmed.2019-0488_bib15","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1007\/s00277-012-1510-6","article-title":"Radiotherapy for solitary plasmacytoma of bone and soft tissue: Outcomes and prognostic factors","volume":"91","author":"Suh","year":"2012","journal-title":"Ann Hematol"},{"key":"10.7861\/clinmed.2019-0488_bib16","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/bjh.13870","article-title":"Clinical features and prognostic factors in solitary plasmacytoma","volume":"172","author":"Finsinger","year":"2016","journal-title":"Br J Haematol"},{"key":"10.7861\/clinmed.2019-0488_bib17","doi-asserted-by":"crossref","first-page":"e0219857","DOI":"10.1371\/journal.pone.0219857","article-title":"Long-term clinical outcomes in a cohort of patients with solitary plasmacytoma treated in the modern era","volume":"14","author":"Sharpley","year":"2019","journal-title":"PLoS One"},{"key":"10.7861\/clinmed.2019-0488_bib18","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13045-017-0549-1","article-title":"Diagnosis, treatment, and response assessment in solitary plasmacytoma: updated recommendations from a European Expert Panel","volume":"11","author":"Caers","year":"2018","journal-title":"J Hematol Oncol"},{"key":"10.7861\/clinmed.2019-0488_bib19","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/(SICI)1099-1069(199609)14:3<111::AID-HON575>3.0.CO;2-G","article-title":"Improved outcome in solitary bone plasmacytomata with combined therapy","volume":"14","author":"Avil\u00e9s","year":"1996","journal-title":"Hematol Oncol"},{"key":"10.7861\/clinmed.2019-0488_bib20","author":"University College, London","year":"2019","journal-title":"Trial of immunomodulatory therapy in high risk solitary bone plasmacytoma (IDRIS)"},{"key":"10.7861\/clinmed.2019-0488_bib21","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1093\/annonc\/mdw606","article-title":"Second primary malignancies in multiple myeloma: an overview and IMWG consensus","volume":"28","author":"Musto","year":"2017","journal-title":"Ann Oncol"},{"key":"10.7861\/clinmed.2019-0488_bib22","doi-asserted-by":"crossref","first-page":"4086","DOI":"10.1182\/blood-2011-05-355743","article-title":"Risk of acute myeloid leukemia and myelodysplastic syndromes after multiple myeloma and its precursor disease (MGUS)","volume":"118","author":"Mailankody","year":"2011","journal-title":"Blood"},{"key":"10.7861\/clinmed.2019-0488_bib23","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1182\/blood-2011-12-381426","article-title":"Second malignancies after multiple myeloma: From 1960s to 2010s","volume":"119","author":"Thomas","year":"2012","journal-title":"Blood"}],"container-title":["Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1470211824035061?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1470211824035061?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.7861\/clinmed.2019-0488","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T06:39:38Z","timestamp":1761460778000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1470211824035061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S1470211824035061"],"URL":"https:\/\/doi.org\/10.7861\/clinmed.2019-0488","relation":{},"ISSN":["1470-2118"],"issn-type":[{"value":"1470-2118","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical presentation and outcomes of solitary plasmacytoma in a tertiary hospital in the UK","name":"articletitle","label":"Article Title"},{"value":"Clinical Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.7861\/clinmed.2019-0488","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 Royal College of Physicians 2020. All rights reserved.","name":"copyright","label":"Copyright"}]}}